RESMED INC 10-Q

Item 5 Other Information None ‎ 33 Table of Contents PART II – OTHER INFORMATION Item 1-6 RESMED INC. AND SUBSIDIARIES Item 6 Exhibits Exhibits (numbered in accordance with Item 601 of Regulation S-K) 3.1 First Restated Certificate of Incorporation of ResMed Inc., as amended. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Report on Form 10-Q for the quarter ended September 30, 2013) 3.2 Sixth Amended and Restated Bylaws of ResMed Inc. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 26, 2020) 31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101 The following financial statements from ResMed Inc.’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2020, filed on January 28, 2021, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) the Notes to the Condensed Consolidated Financial Statements. 34 Table of Contents PART II – OTHER INFORMATION Signatures RESMED INC. AND SUBSIDIARIES Signatures We have authorized the persons whose signatures appear below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. January 28, 2021 ResMed Inc. /s/ MICHAEL J. FARRELL Michael J. Farrell Chief executive officer (Principal Executive Officer) /s/ BRETT A. SANDERCOCK Brett A. Sandercock Chief financial officer (Principal Financial Officer) 35